Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Stem Cell Research
|
September 20, 2017
Generation of an induced pluripotent stem cell line from a patient with hereditary multiple endocrine neoplasia 2B (MEN2B) syndrome with "highest risk" RET mutation
A Bennaceur-Griscelli, J Hadoux, O Féraud, et al.
Cardiovascular Research
|
February 13, 2001
Adenoviral SERCA1a gene transfer to adult rat ventricular myocytes induces physiological changes in calcium handling
N Chossat, F Griscelli, P Jourdon, et al.
Stem Cell Research
|
August 26, 2016
Generation of an induced pluripotent stem cell line from a patient with hereditary multiple endocrine neoplasia 2A (MEN2A) syndrome with RET mutation
J Hadoux, O Féraud, F Griscelli, et al.
Gene Therapy
|
September 1, 2006
Dynamic assessment of antiangiogenic therapy by monitoring both tumoral vascularization and tissue degeneration
C Magnon, A Galaup, V Rouffiac, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 24, 2000
Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model
F Griscelli, H Li, C Cheong, et al.
Human Gene Therapy
|
December 28, 1999
Systemic delivery of antiangiogenic adenovirus AdmATF induces liver resistance to metastasis and prolongs survival of mice
H Li, F Griscelli, F Lindenmeyer, et al.
Gene Therapy
|
May 18, 1999
Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice
H Li, H Lu, F Griscelli, et al.
Gene Therapy
|
February 26, 2003
Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patients
F Griscelli, P Opolon, P Saulnier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2020
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
J-M Michot, L Albiges, N Chaput, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 5, 2021
Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies
F Pommeret, J Colomba, C Bigenwald, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Stem Cell Research
|
September 20, 2017
Generation of an induced pluripotent stem cell line from a patient with hereditary multiple endocrine neoplasia 2B (MEN2B) syndrome with "highest risk" RET mutation
A Bennaceur-Griscelli, J Hadoux, O Féraud, et al.
Cardiovascular Research
|
February 13, 2001
Adenoviral SERCA1a gene transfer to adult rat ventricular myocytes induces physiological changes in calcium handling
N Chossat, F Griscelli, P Jourdon, et al.
Stem Cell Research
|
August 26, 2016
Generation of an induced pluripotent stem cell line from a patient with hereditary multiple endocrine neoplasia 2A (MEN2A) syndrome with RET mutation
J Hadoux, O Féraud, F Griscelli, et al.
Gene Therapy
|
September 1, 2006
Dynamic assessment of antiangiogenic therapy by monitoring both tumoral vascularization and tissue degeneration
C Magnon, A Galaup, V Rouffiac, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 24, 2000
Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model
F Griscelli, H Li, C Cheong, et al.
Human Gene Therapy
|
December 28, 1999
Systemic delivery of antiangiogenic adenovirus AdmATF induces liver resistance to metastasis and prolongs survival of mice
H Li, F Griscelli, F Lindenmeyer, et al.
Gene Therapy
|
May 18, 1999
Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice
H Li, H Lu, F Griscelli, et al.
Gene Therapy
|
February 26, 2003
Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patients
F Griscelli, P Opolon, P Saulnier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2020
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
J-M Michot, L Albiges, N Chaput, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 5, 2021
Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies
F Pommeret, J Colomba, C Bigenwald, et al.
Page
of 3